Compare BAX & EVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BAX | EVR |
|---|---|---|
| Founded | 1931 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.9B | 13.7B |
| IPO Year | 1994 | 2006 |
| Metric | BAX | EVR |
|---|---|---|
| Price | $26.26 | $289.27 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 8 |
| Target Price | $21.00 | ★ $359.38 |
| AVG Volume (30 Days) | ★ 7.5M | 558.4K |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | 0.24% | ★ 1.04% |
| EPS Growth | N/A | ★ 54.74 |
| EPS | 0.21 | ★ 9.56 |
| Revenue | ★ $11,244,000,000.00 | $3,880,084,000.00 |
| Revenue This Year | $1.96 | $22.69 |
| Revenue Next Year | $2.22 | $13.31 |
| P/E Ratio | $126.19 | ★ $30.48 |
| Revenue Growth | 5.72 | ★ 29.49 |
| 52 Week Low | $15.73 | $265.87 |
| 52 Week High | $30.00 | $388.71 |
| Indicator | BAX | EVR |
|---|---|---|
| Relative Strength Index (RSI) | 53.03 | 37.82 |
| Support Level | $25.75 | $265.87 |
| Resistance Level | $30.00 | $353.60 |
| Average True Range (ATR) | 0.65 | 8.56 |
| MACD | -0.27 | -0.03 |
| Stochastic Oscillator | 13.69 | 21.62 |
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
Evercore is a leading independent investment banking advisory firm that generates most of its revenue through merger and acquisition and restructuring advisory services, with much smaller capital raising, equities trading, and investment management businesses. Founded in 1995, it has built a reputation for advising on some of the world's largest and most complex transactions. Evercore operates globally, with a strong presence in the US and Europe, serving corporations, financial sponsors, and government clients. Its business model emphasizes high-touch, conflict-free advice rather than balance sheet lending, allowing it to compete with larger bulge-bracket banks.